Cell Biology: Research & TherapyISSN: 2324-9293

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article,  Cell Bio Vol: 10 Issue: 7

Synergistic Impact Of Combined Zoledronic Acid / 5-FU And Zoledronic Acid / Flutamide On The Expression Of MiR-382, MiR-18a, Bcl - 2 And P53 In PC- 3 Cancer Cells.

Amr M. Yehia1*, Mahmoud G. Eldeib1, Ahmed M. Mohamadin1,Mohammed M. El-Zahabi1

Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Almokhayam Aldaem Street, 6th Province - 13465 Nasr City, Cairo, Egypt.

*Corresponding Author:
M. Yehia1 1-Biochemistry and Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Almokhayam Aldaem Street, 6th Province - 13465 Nasr City, Cairo, Egypt 13465 Nasr City, Cairo, Egypt. Email: amr_yehia@azhar.edu.eg

Citation: M. Yehia1 A, et al. (2021) Story of the Most Triggering Issue of the Globe: 2019 Novel Coronavirus (COVID �?? 19). Cell Bio.

Abstract

Introduction/Aims: assessment of the chemotherapeutic effect of zoledronic acid (ZA) when combined with 5-FU or Flutamide on prostate cancer cell line (PC-3), through estimation of synergistic effects of combinations on cytotoxicity, expression of miRNAs and apoptosis. Methods: cell viability was assessed by MTT assay. Different concentrations of combined ZA/5-FU and ZA/Flutamide were applied to PC-3 and were compared to single drug treatment for 48 h. Changes in miR-18a and miR-382 expressions after treatment were determined using quantitative real time-polymerase chain reaction (qRT-PCR). Immunofluorescence staining analysis was used to assess the changes in Bcl-2 and p53 expression. Results: IC50 of ZA, 5-FU, and Flutamide was 13.47 μM, 8.23 μM and 9.42 μM respectively. While the combination index (CI) of ZA/5-FU and ZA/Flutamide reached a level of synergistic effects at the combination of ¼ IC50 of each. The combination therapy was associated with over-expression of miR-382, down-expression of miR-18a, reduced Bcl-2 and enhanced p53 expressions. Conclusion: ZA/5-FU and ZA/Flutamide combinations offer interesting chemotherapeutic effects with lower doses and synergistic effects more than treatment with single drugs to be further investigated.

Keywords: Prostate cancer, Zoledronic acid, miR-18a, miR-382

international publisher, scitechnol, subscription journals, subscription, international, publisher, science

Track Your Manuscript

Awards Nomination

open access